HIV+Hep in the News

;

Court strikes down federal rule that sharply increased prescription costs for many patients

by | Oct 2, 2023

“We are thrilled that the court has taken the side of patients who have been struggling to afford their prescription drugs,” Carl Schmid, the executive director of the HIV+Hepatitis Policy Institute, one of the patient-advocacy groups behind the case, said in a statement. The Biden administration should immediately enforce the decision, Schmid added, and “not take any further steps to undermine the copay assistance that allows patients to access their essential medications.”

read more

Court strikes down Trump-era rule that allowed health insurers to broadly use copay accumulators

by | Oct 2, 2023

U.S. judge has struck down a Trump administration rule that allowed health insurers not to count copay assistance offered by drug companies toward out-of-pocket costs, a victory for advocacy groups that argued the rule harmed patient health. At issue is the complex and often opaque health insurance system in the U.S., which has prompted long-running battles between drugmakers and insurers over the cost of prescription medicines.

read more

Judge strikes down medicare’s Trump-era copay assistance rule

by | Oct 2, 2023

“We are thrilled that the Court has taken the side of patients who have been struggling to afford their prescription drugs due to the greedy actions of insurers and their PBMs,” Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, said in a statement Monday. “We call on the Biden administration and states to immediately enforce this decision and not take any further steps to undermine the copay assistance that allows patients to access their essential medications.”

read more

Court axes rule that let insurers not count copay assistance toward patient costs

by | Oct 2, 2023

Advocates celebrated the decision as a win for patients, calling on HHS to now enforce the provision in the earlier 2020 exchange rule that had barred most co-pay accumulators and issue new guidance. “We call on the Biden administration and states to immediately enforce this decision and not take any further steps to undermine the copay assistance that allows patients to access their essential medications,” Carl Schmid, executive director of the HIV + Hepatitis Policy Institute, said.

read more

Partisanship, Funding And Privacy Concerns Could Obstruct PrEP Access

by | Sep 18, 2023

A lack of funding, fears around data sequestration, and resistance to expanding sexual health measures are all reasons pointing to delays for increasing access to PrEP for uninsured and underinsured patients. While the U.S. Preventive Services Task Force (USPSTF) last month made headway for insured patients by giving it an “A” grade, questions remain about access for those without insurance.

read more

Search

Pin It on Pinterest

Share This